Arca
Skip to content
Tools
Tools

Warning Letter to Namsa

Biologics. See NAMSA's company page or this site's inspections.

On Oct 7, 2022, FDA's CDRH sent Namsa a warning letter citing capa.

  • Letter date: Oct 7, 2022
  • Issued by: CDRH
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

Dear Dr. Chakraborty:

The FDA has completed an evaluation of your firm’s corrective and preventive actions in response to our Warning Letter (WL) dated March 23, 2018, and the follow up inspection conducted on August 30, 2021, to September 21,2021. Based on our evaluation, it appears that your firm has adequately addressed the violations contained in the WL and in the one item FDA Form-483, dated September 21, 2021, and has implemented the corrective actions, as promised in your response letters, dated October 11, 2021, December 31, 2021, April 3, 2022, and July 7, 2022.

This letter does not relieve your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(h), and its implementing regulations. The FDA expects your firm to maintain compliance and this letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely yours, /S/ Sheena Green, MS Assistant Director DCEA1: Division of Clinical Policy and Quality OCEA: Office of Clinical Evidence and Analysis Office of Product Evaluation and Quality Center for Devices and Radiological Health

The Firm's Other Letters

Same company or the same FDA site, newest first
  • NamsaMar 23, 2018 · CDRH · CAPA, 510(k) required

Recent Letters Citing CAPA

See them all

Record

Recipient
Pinaki Chakraborty, MS, Ph.D., MBA
FDA site ID (FEI)
3010138955
Cited
CAPA

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.